Your Best Stock
Stocks Biotechnology ARGX

argenx SE ARGX

US equityMarket cap rank #269Biotechnology
$952.95
+$7.13 (+0.75%)
Market open · Sep 24, 1:10 pm ET
After hours $945.82 0.00%
Open$945.81
Prev close$945.82
Day range$944.21 – $965.27
Volume192.4K
Market cap$59.62B
P/E (TTM)36.3
Dividend yield

Earnings

Average move on report day±4.3%last 15 reports
Closed higher7 of 1547% of the time
Best reaction+11.9%
Worst reaction-8.6%

Stock move on the day after each report

+1.2%2023/Q3-4.4%2023/Q4-0.9%2024/Q1+4.7%2024/Q2+6.3%2024/Q3+0.3%2024/Q4-8.6%2025/Q1+11.9%2025/Q2-0.2%2025/Q3-5.6%2025/Q4-2.5%2026/Q1+8.6%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q322 Oct 2026Pre Market
2026/Q223 Jul 2026Pre Market±74.4%+8.56%Within range
2026/Q17 May 2026Pre Market±48.9%-2.51%Within range
2025/Q426 Feb 2026Pre Market±65.9%-5.56%Within range
2025/Q330 Oct 2025±71.2%-0.20%Within range
2025/Q231 Jul 2025±50.6%+11.93%Within range
2025/Q18 May 2025±39.8%-8.64%Within range
2024/Q427 Feb 2025±68.0%+0.27%Within range
2024/Q331 Oct 2024Pre Market±42.5%+6.27%Within range
2024/Q225 Jul 2024±41.8%+4.73%Within range
2024/Q19 May 2024±21.0%-0.91%Within range
2023/Q429 Feb 2024±30.5%-4.45%Within range
2023/Q331 Oct 2023±48.7%+1.17%Within range
2023/Q227 Jul 2023±33.5%-2.29%Within range
2023/Q14 May 2023Pre Market±37.8%+0.80%Within range
2022/Q42 Mar 2023±24.0%-6.48%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2025/FY

By region

  • United States$3.53B 85.1%
  • Rest of the World$342.62M 8.3%
  • Japan$206.84M 5.0%
  • China$67.92M 1.6%

Latest reported quarter: Q2, ended Jun 2026

Revenue$1.52B+59.6% YoY
Operating profit$494.00M+145.8% YoY
Net profit$472.00M+91.9% YoY
Diluted EPS$7.48+100.0% YoY
Free cash flow$267,297.05+113.2% YoY
Operating cash flow$309,579.13

Revenue, last 8 quarters

$573.0MSep '24$741.3MDec '24$790.0MMar '25$949.0MJun '25$1.1BSep '25$1.3BDec '25$1.3BMar '26$1.5BJun '26

Net profit, last 8 quarters

$91.4MSep '24$774.2MDec '24$169.0MMar '25$246.0MJun '25$344.3MSep '25$533.0MDec '25$366.0MMar '26$472.0MJun '26

Profitability & balance sheet

Gross margin90.0%
Operating margin30.7%
Net margin32.8%
Return on equity23.6%
Return on assets19.9%
Return on invested capital21.1%
Current ratio5.12
Liabilities / assets16.1%
Cash & investments$5.18B
Total debt$36.00M
Net cash (debt)$5.15B
Free cash flow / sales17.3%
Scroll to Top